219 related articles for article (PubMed ID: 2415821)
1. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
Veith R; Galanello R; Papayannopoulou T; Stamatoyannopoulos G
N Engl J Med; 1985 Dec; 313(25):1571-5. PubMed ID: 2415821
[TBL] [Abstract][Full Text] [Related]
2. Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis.
Letvin NL; Linch DC; Beardsley GP; McIntyre KW; Miller BA; Nathan DG
J Clin Invest; 1985 Jun; 75(6):1999-2005. PubMed ID: 2409112
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
Rodgers GP
Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
[TBL] [Abstract][Full Text] [Related]
4. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
[TBL] [Abstract][Full Text] [Related]
5. Increasing fetal hemoglobin production in sickle cell disease: results of clinical trials.
Dover GJ; Charache S
Prog Clin Biol Res; 1987; 251():455-66. PubMed ID: 2448813
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons.
Al-Khatti A; Veith RW; Papayannopoulou T; Fritsch EF; Goldwasser E; Stamatoyannopoulos G
N Engl J Med; 1987 Aug; 317(7):415-20. PubMed ID: 2441258
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
Galanello R; Veith R; Papayannopoulou T; Stamatoyannopoulos G
Prog Clin Biol Res; 1985; 191():433-45. PubMed ID: 2413479
[No Abstract] [Full Text] [Related]
8. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
Trans Assoc Am Physicians; 1984; 97():268-74. PubMed ID: 6085528
[No Abstract] [Full Text] [Related]
9. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production.
Dover GJ; Humphries RK; Moore JG; Ley TJ; Young NS; Charache S; Nienhuis AW
Blood; 1986 Mar; 67(3):735-8. PubMed ID: 2418898
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate.
McDonagh KT; Dover GJ; Donahue RE; Nathan DG; Agricola B; Byrne E; Nienhuis AW
Exp Hematol; 1992 Nov; 20(10):1156-64. PubMed ID: 1385194
[TBL] [Abstract][Full Text] [Related]
11. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
Dover GJ; Charache S; Boyer SH
Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
[No Abstract] [Full Text] [Related]
12. Regulation of fetal hemoglobin synthesis by cell cycle specific drugs.
Nathan DG
Prog Clin Biol Res; 1985; 191():475-500. PubMed ID: 2413483
[No Abstract] [Full Text] [Related]
13. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
J Clin Invest; 1984 Aug; 74(2):652-6. PubMed ID: 6205021
[TBL] [Abstract][Full Text] [Related]
14. Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.
Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
Prog Clin Biol Res; 1989; 316B():281-93. PubMed ID: 2482498
[No Abstract] [Full Text] [Related]
15. Treatment of sickle cell anemia with hydroxyurea and erythropoietin.
Goldberg MA; Brugnara C; Dover GJ; Schapira L; Charache S; Bunn HF
N Engl J Med; 1990 Aug; 323(6):366-72. PubMed ID: 1695325
[TBL] [Abstract][Full Text] [Related]
16. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.
Ballas SK; McCarthy WF; Guo N; Brugnara C; Kling G; Bauserman RL; Waclawiw MA
Hemoglobin; 2010; 34(5):424-9. PubMed ID: 20854115
[TBL] [Abstract][Full Text] [Related]
17. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1990 Apr; 322(15):1037-45. PubMed ID: 1690857
[TBL] [Abstract][Full Text] [Related]
18. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
[TBL] [Abstract][Full Text] [Related]
19. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease.
Odièvre MH; Bony V; Benkerrou M; Lapouméroulie C; Alberti C; Ducrocq R; Jacqz-Aigrain E; Elion J; Cartron JP
Haematologica; 2008 Apr; 93(4):502-10. PubMed ID: 18322255
[TBL] [Abstract][Full Text] [Related]
20. Treatment of baboon with vinblastine: insights into the mechanisms of pharmacologic stimulation of Hb F in the adult.
Veith R; Papayannopoulou T; Kurachi S; Stamatoyannopoulos G
Blood; 1985 Aug; 66(2):456-9. PubMed ID: 2410070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
